Close



Feb 2, 2024 12:00PM
Feb 2, 2024 12:00PM
Jan 4, 2024 07:06AM
Jan 4, 2024 07:00AM
Dec 7, 2023 07:00AM
Nov 9, 2023 07:00AM
Sep 28, 2023 11:16AM Synlogic (SYBX) Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism
Sep 28, 2023 11:15AM
Aug 10, 2023 07:00AM
Jul 11, 2023 07:00AM
Jul 11, 2023 07:00AM
Jun 28, 2023 07:00AM
Jun 5, 2023 06:45AM
Jun 5, 2023 06:45AM Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
May 11, 2023 06:50AM
May 9, 2023 06:51AM
May 9, 2023 06:50AM
Mar 29, 2023 06:40AM
Mar 28, 2023 06:53AM
Mar 28, 2023 06:52AM
Jan 19, 2023 06:58AM Synlogic (SYBX) Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria
Jan 19, 2023 06:58AM
Jan 5, 2023 06:58AM
Jan 5, 2023 06:58AM
Dec 15, 2022 07:02AM
Dec 15, 2022 06:59AM
Nov 30, 2022 04:20PM
Nov 30, 2022 04:15PM Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update
Oct 18, 2022 06:59AM
Oct 18, 2022 06:59AM
Aug 23, 2022 07:01AM
Aug 23, 2022 07:00AM
May 24, 2022 07:03AM
May 24, 2022 07:00AM
Apr 28, 2022 07:00AM Synlogic Announces Data Presentations at the 2022 Genetic Metabolic Dieticians International (GMDI) Conference and Garrod Symposium
Apr 26, 2022 07:00AM
Apr 1, 2022 07:00AM
Mar 17, 2022 07:00AM
Jan 6, 2022 07:05AM
Jan 6, 2022 07:00AM
Nov 24, 2021 09:19AM
Nov 9, 2021 07:00AM Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria
Aug 6, 2020 04:02PM
Aug 20, 2019 09:16AM
May 22, 2019 07:00AM
Jan 3, 2019 08:00AM
Nov 7, 2018 04:23PM
May 15, 2018 07:00AM
Apr 25, 2018 07:12AM Synlogic (SYBX) Receives Fast-Track Designation for SYNB1618
Apr 25, 2018 07:00AM

251,531 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All